0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Oncology Market by Animal Type (Canine, Equine, Exotic Pets), Treatment Mode (Chemotherapy, Immunotherapy, Radiotherapy), Cancer Type, Mode of Administration, End User - Global Forecast 2025-2030- Product Image
Veterinary Oncology Market by Animal Type (Canine, Equine, Exotic Pets), Treatment Mode (Chemotherapy, Immunotherapy, Radiotherapy), Cancer Type, Mode of Administration, End User - Global Forecast 2025-2030- Product Image
Sale

Veterinary Oncology Market by Animal Type (Canine, Equine, Exotic Pets), Treatment Mode (Chemotherapy, Immunotherapy, Radiotherapy), Cancer Type, Mode of Administration, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305503
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The veterinary oncology market is undergoing significant transformation, driven by technological advances, evolving clinical demand, and the integration of personalized care solutions for companion animals. For senior decision-makers across the animal health sector, staying ahead of these developments is now essential to maintaining competitiveness and delivering value throughout the care continuum.

Market Snapshot: Veterinary Oncology Market Growth and Trajectory

The Veterinary Oncology Market grew from USD 1.61 billion in 2024 to USD 1.84 billion in 2025. It is expected to continue growing at a CAGR of 14.01%, reaching USD 3.55 billion by 2030. Market momentum is shaped by rising pet ownership, increasing disposable incomes, and demand for advanced cancer treatment in veterinary medicine. Companies and institutions across the globe are rapidly investing in innovative therapies, digital tools, and diagnostics, responding to the evolving clinical landscape and shifting regulatory needs.

Scope & Segmentation: Strategic Overview of Key Segments and Regions

  • Animal Types: Canine, Equine, Feline, Exotic Pets (including aquatic pets, birds, reptiles, and amphibians)
  • Treatment Modes: Chemotherapy (alkylating agents, antimetabolites, cytotoxic agents, vinca alkaloids), Immunotherapy (cancer vaccines, monoclonal antibodies), Radiotherapy (brachytherapy, external beam radiotherapy), Surgery, Targeted Therapy
  • Cancer Classifications: Hemangiosarcoma, Lymphoma, Mammary Carcinoma, Mast Cell Tumors, Osteosarcoma
  • Administration Routes: Intravenous (IV), Oral, Topical
  • End Users: Academic Institutions, Veterinary Hospitals & Clinics
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, South Africa, and more), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, among others)
  • Core Players Analyzed: AB Science SA, Anivive Lifesciences, Ardent Animal Health LLC, Boehringer Ingelheim International GmbH, Ceva Sante Animale SA, Covetrus Inc., Elanco Animal Health Incorporated, ELIAS Animal Health, Fidocure, IDEXX Laboratories Inc., Karyopharm Therapeutics Inc., Leroy Biotech SAS, Merck KGaA, Morphogenesis Inc., Nippon Zenyaku Kogyo Co. Ltd., PetCure Oncology LLC, PharmAust Limited, Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., Varian Medical Systems Inc., Vetco Pharmaceuticals Inc., VetDC Inc., Virbac SA, VolitionRx Limited, Zoetis Inc.

Key Takeaways: Strategic Insights for Leaders

  • Advanced diagnostics and digital imaging platforms are improving both the accuracy and speed of cancer detection, leading to earlier intervention and better treatment planning.
  • Immunotherapy is increasingly integrated into standard care protocols, moving from experimental stages to routine use for various animal cancers.
  • The uptake of telemedicine and remote consultation services is expanding specialist reach, addressing gaps in regions with limited access to veterinary oncologists.
  • Regulatory frameworks are adapting to accommodate new therapeutic modalities, prompting industry players to align their research and commercialization strategies accordingly.
  • Regional variability requires tailored go-to-market approaches; while developed markets embrace advanced therapies quickly, emerging regions are catching up as investments in clinical infrastructure grow.
  • Collaboration between biotechnology companies and academic centers is driving translational research, accelerating clinical application of laboratory breakthroughs.

Tariff Impact: How Policy Changes Shape Supply Chains and Research

Recent United States tariff adjustments on pharmaceuticals and diagnostic equipment have impacted supply chain cost structures in the veterinary oncology market. Manufacturers are reassessing sourcing models, while clinics and hospitals face tighter margins as a result of changes in raw material pricing and equipment availability. These shifts are encouraging greater domestic production, new supplier agreements, and agile procurement strategies. Delays in access to advanced imaging systems have affected research timelines, underscoring the need for proactive risk mitigation in supply chain management.

Methodology & Data Sources

This report utilizes a mixed methods approach, combining rigorous secondary research—including peer-reviewed literature, regulatory documentation, and industry white papers—with primary interviews conducted among industry experts, clinical researchers, and product leaders. Findings are triangulated through multiple sources, with external validation provided by an independent advisory board, ensuring data reliability and actionable insights.

Why This Report Matters

  • Enables decision-makers to anticipate disruptive trends and adjust business strategy for sustained growth in veterinary oncology.
  • Supports informed investment and partnership decisions by offering clear analysis of technology adoption, regional dynamics, and competitive developments.
  • Guides organizations in building resilient supply chains and aligning with evolving regulatory environments to maintain operational continuity and margin stability.

Conclusion

The veterinary oncology market is advancing across clinical, technological, and geographical boundaries. As the competitive landscape intensifies, organizations that combine strategic innovation with operational resilience will be best positioned for long-term success in animal cancer care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of targeted immunotherapy treatments for companion animal cancers driving market growth
5.2. Increasing use of liquid biopsy diagnostics for early detection of canine and feline tumors reducing treatment costs
5.3. Strategic partnerships between biotech firms and veterinary clinics to accelerate personalized cancer therapies in pets
5.4. Rising demand for minimally invasive radiation therapy for small animal oncology boosting procedural volumes
5.5. Expanding regulatory approvals for novel veterinary chemotherapeutics enhancing treatment portfolios across regions
5.6. Growth of telemedicine platforms for remote oncology consultations improving access to canine cancer specialists
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Oncology Market, by Animal Type
8.1. Introduction
8.2. Canine
8.3. Equine
8.4. Exotic Pets
8.4.1. Aquatic Pets
8.4.2. Birds
8.4.3. Reptiles & Amphibians
8.5. Feline
9. Veterinary Oncology Market, by Treatment Mode
9.1. Introduction
9.2. Chemotherapy
9.2.1. Alkylating Agents
9.2.2. Antimetabolites
9.2.3. Cytotoxic Agents
9.2.4. Vinca Alkaloids
9.3. Immunotherapy
9.3.1. Cancer Vaccines
9.3.2. Monoclonal Antibodies
9.4. Radiotherapy
9.4.1. Brachytherapy
9.4.2. External Beam Radiotherapy
9.5. Surgery
9.6. Targeted Therapy
10. Veterinary Oncology Market, by Cancer Type
10.1. Introduction
10.2. Hemangiosarcoma
10.3. Lymphoma
10.4. Mammary Carcinoma
10.5. Mast Cell Tumors
10.6. Osteosarcoma
11. Veterinary Oncology Market, by Mode of Administration
11.1. Introduction
11.2. Intravenous (IV)
11.3. Oral
11.4. Topical
12. Veterinary Oncology Market, by End User
12.1. Introduction
12.2. Academic Institutions
12.3. Veterinary Hospitals & Clinics
13. Americas Veterinary Oncology Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Veterinary Oncology Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Veterinary Oncology Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AB Science SA
16.3.2. Anivive Lifesciences
16.3.3. Ardent Animal Health, LLC
16.3.4. Boehringer Ingelheim International GmbH
16.3.5. Ceva Sante Animale S.A.
16.3.6. Covetrus, Inc.
16.3.7. Elanco Animal Health Incorporated
16.3.8. ELIAS Animal Health
16.3.9. Fidocure
16.3.10. IDEXX Laboratories, Inc.
16.3.11. Karyopharm Therapeutics Inc.
16.3.12. Leroy Biotech S.A.S.
16.3.13. Merck KGaA,
16.3.14. Morphogenesis, Inc.
16.3.15. Nippon Zenyaku Kogyo Co., Ltd.
16.3.16. PetCure Oncology LLC
16.3.17. PharmAust Limited
16.3.18. Rhizen Pharmaceuticals AG
16.3.19. Torigen Pharmaceuticals Inc.
16.3.20. Varian Medical Systems, Inc.
16.3.21. Vetco Pharmaceuticals Inc.
16.3.22. VetDC, Inc.
16.3.23. Virbac SA
16.3.24. VolitionRx Limited
16.3.25. Zoetis Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VETERINARY ONCOLOGY MARKET: RESEARCHAI
FIGURE 26. VETERINARY ONCOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 27. VETERINARY ONCOLOGY MARKET: RESEARCHCONTACTS
FIGURE 28. VETERINARY ONCOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY AQUATIC PETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY AQUATIC PETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BIRDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BIRDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REPTILES & AMPHIBIANS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REPTILES & AMPHIBIANS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VINCA ALKALOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VINCA ALKALOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY HEMANGIOSARCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY HEMANGIOSARCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY OSTEOSARCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY OSTEOSARCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 130. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 131. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 132. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 133. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 134. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 135. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 136. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 137. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 138. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 139. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 240. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 241. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 248. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 249. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 258. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 259. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 262. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 263. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 264. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 266. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 267. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 292. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 293. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 294. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 295. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 296. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 297. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 298. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 299. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 300. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 301. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 302. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 303. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 304. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 305. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 312. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 313. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 316. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 317. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 318. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 320. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 321. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 322. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 323. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

  • AB Science SA
  • Anivive Lifesciences
  • Ardent Animal Health, LLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale S.A.
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health
  • Fidocure
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics Inc.
  • Leroy Biotech S.A.S.
  • Merck KGaA,
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • PetCure Oncology LLC
  • PharmAust Limited
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • Varian Medical Systems, Inc.
  • Vetco Pharmaceuticals Inc.
  • VetDC, Inc.
  • Virbac SA
  • VolitionRx Limited
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.55 Billion
Compound Annual Growth Rate14.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type, By Therapy, By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type, By Therapy, By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
EUR$5,950USDGBP
Veterinary Oncology - Global Strategic Business Report - Product Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
EUR$5,850USDGBP
Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
EUR$4,500USDGBP
Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
EUR$5,950USDGBP
Veterinary Oncology Market Report 2025 - Product Image

Veterinary Oncology Market Report 2025

  • Report
  • 175 Pages
  • Global
From
EUR$4,490USDGBP

About the Veterinary Oncology Market

Veterinary Oncology is a specialized field of veterinary medicine that focuses on the diagnosis and treatment of cancer in animals. Veterinary oncologists are trained to diagnose and treat a variety of cancers, including lymphoma, mast cell tumors, and bone cancer. Treatment options may include chemotherapy, radiation therapy, and surgery. Veterinary oncologists also provide supportive care to help animals cope with the side effects of cancer treatment. Veterinary oncology is an important part of animal healthcare, as cancer is a leading cause of death in animals. Veterinary oncologists work closely with other veterinary specialists, such as surgeons and radiologists, to provide comprehensive care for animals with cancer. Some companies in the Veterinary Oncology market include VetDC, VetCancer, and VetCure Oncology. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more